1. Home
  2. CHGG vs UNCY Comparison

CHGG vs UNCY Comparison

Compare CHGG & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chegg Inc.

CHGG

Chegg Inc.

HOLD

Current Price

$0.94

Market Cap

103.4M

Sector

Real Estate

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.23

Market Cap

121.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHGG
UNCY
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.4M
121.9M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
CHGG
UNCY
Price
$0.94
$6.23
Analyst Decision
Sell
Strong Buy
Analyst Count
5
4
Target Price
$1.42
$44.50
AVG Volume (30 Days)
1.7M
384.0K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$447,733,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.44
$3.71
52 Week High
$2.40
$11.00

Technical Indicators

Market Signals
Indicator
CHGG
UNCY
Relative Strength Index (RSI) 45.50 57.10
Support Level $0.83 $6.31
Resistance Level $0.99 $6.95
Average True Range (ATR) 0.08 0.42
MACD 0.02 -0.00
Stochastic Oscillator 56.50 53.72

Price Performance

Historical Comparison
CHGG
UNCY

About CHGG Chegg Inc.

Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: